News

Next Generation Germanium-68/Gallium-68 Generator

ITM Isotopen Technologien München AG (ITM), a biotechnology and radiopharmaceutical group of companies in Germany, and RadioMedix Inc., a clinical stage biotechnology company in Houston, Texas, announced  on December 8, 2020, that the U.S. Food …

NANETS 2020 Grant Recipients

Exciting news from NANETS, the North American Neuroendocrine Tumor Society, about the 2020 Research Grant Recipients. Congratulations to Dr. Heloisa Soares of the Huntsman Cancer Institute, University of Utah; Dr. Xavier Keutgen of the University…

2020 Monica Warner Award: Call for Nominations until 1/12/21

Advanced Accelerator Applications (AAA), a Novartis company, has announced that nominations are open for the 11th Annual Monica Warner Award!  AAA is continuing the Novartis tradition of sponsoring the award, which commemorates the life and work …

Detectnet Transitional Pass-Through Status Granted by Centers for Medicare and Medicaid Services

RadioMedix Inc. and its commercial partner, Curium, announced today, December 9, 2020, that the Centers for Medicare & Medicaid Services (CMS) “has granted Detectnet Transitional Pass-Through Status (code C9068) effective January 1, 2021. …

Carcinoid Syndrome: 3 New Virtual Events in December

Are you newly diagnosed with carcinoid syndrome or have been living with the syndrome for many years? The neuroendocrine tumor (NET) community is invited to participate in three new, virtual carcinoid syndrome programs in December. The programs are…

Giving Tuesday, December 1

Pancreatic Neuroendocrine Tumors Facebook Live Webinar, Now Available for Viewing at Your Convenience

The American Association of Endocrine Surgeon’s November 19th Facebook live, free webinar focusing on Pancreatic Neuroendocrine Tumors with a panel of NET experts is now available for viewing at your convenience. Click here to watch the webinar: …

New NET Video in Honor of NET Cancer Awareness Month

To commemorate Neuroendocrine Cancer Awareness Month in November and World #NETCancerDay on November 10, and in recognition of all lives touched by neuroendocrine cancer, Sun Pharma has sponsored the creation of the NET Effects video. The insights,…

Pancreatic Neuroendocrine Tumors Facebook Live Webinar, November 19

Save the date for a Facebook live, free webinar focusing on Pancreatic Neuroendocrine Tumors with a panel of NET experts!

After the LIVE event, the webinar will remain on the AAES Facebook page here, https://www.facebook.com/TheAAES. 

When: Thursday,…

NEW Survey: Understanding Patient Preferences in NET Treatments (CLOSING SOON!)

When you meet with your healthcare team do you discuss what is important to you as you consider treatment options?  You can help physicians better understand patient-centered treatment decision making by participating in this new, international …